Device Negative Pressure Systems & Dressings

Prevena Restor Arthroform

Payments companies reported to CMS as associated with Prevena Restor Arthroform. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$706Kassociated payments (2023-2025)
450clinicians with associated payments
2companies reporting

By year

2023 $353K
2024 $301K
2025 $52K

Payments reported as associated with Prevena Restor Arthroform, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $279K
Adult Reconstructive Orthopaedic Surgery $118K
Plastic Surgery $89K
Surgery $57K
Vascular Surgery $40K
Orthopaedic Trauma $25K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Prevena Restor Arthroform

These are the largest totals companies reported as associated with Prevena Restor Arthroform. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Timothy Alton Renton, WA Orthopaedic Surgery $80,089.67
Herbert Cooper New York, NY Adult Reconstructive Orthopaedic Surgery $72,019.31
Frank Buttacavoli San Antonio, TX Orthopaedic Surgery $56,682.89
Abhishek Chatterjee Lebanon, NH Surgery $35,861.26
Devinder Singh Miami, FL Plastic Surgery $30,496.29
Carlos Higuera Rueda Weston, FL Orthopaedic Surgery $29,263.97
Javad Parvizi Philadelphia, PA Adult Reconstructive Orthopaedic Surgery $26,550.55
Ellen Dillavou Raleigh, NC Vascular Surgery $22,889.04
Ravi Karia San Antonio, TX Orthopaedic Surgery $18,248.43
John Fischer Philadelphia, PA Plastic Surgery $17,805.28

Prescribed Prevena Restor Arthroform?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.